Afatinib is an orally administered drug that is only available in tablet form. It should be taken on an empty stomach at least 1 hour before or 2 hours after a meal, as absorption decreases with high-fat meals. The tablet should be swallowed whole with at least 8 ounces of water. The tablet should never be crushed or dissolved. The storage of this tablet should be at room temperature (68 F to 77 F). The recommended dosage is 40 mg tablets daily in a patient with normal creatinine and without any major liver dysfunction until disease progression or the patient no longer tolerates it.Â Following oral administration, the time to peak plasma concentration (Tmax) is reported to be between 2 to 5 hours.

This medication is available in the following form/doses:

- Tablet: 20 mg, 30 mg and 40 mg

For both non-small cell and squamous non-small cell metastatic cancers, dosing is 40 mg orally once daily, preferably more than an hour before or 2 hours after food.

The treatment dosing adjustments for creatinine clearance:

- CrCl 30 to 89 ml/min/1.73 m2: no dosage adjustment necessary

- CrCl 15 to 29 ml/min/1.73 m2: 30 mg PO daily

- CrCl less than 15 ml/min/1.73 m2: Not studied

The treatment dosage for hepatic impairment:

- Mild-Moderate (Child-Pugh A or B): No dosage adjustment is necessary

- Severe (Child-Pugh C): Closely monitor and adjust the dose if not tolerated